FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2946974785> ?p ?o ?g. }

• W2946974785 abstract "Fulminant liver failure (FHF) is a serious clinical problem and liver transplantation is the major intervention. But the overall survival rate of FHF is low owing to the donated organ shortage. Apolipoprotein A-V (ApoA5) is a regulator of triglyceride metabolism and has been reported to act as a predictor for remnant liver growth after preoperative portal vein embolization and liver surgery. This study aimed to investigate the therapeutic effect of ApoA5 on lipopolysaccharide/d-galactosamine (LPS/d-GalN)—induced fulminant liver failure in mice. FHF mouse model was established using LPS/d-GalN and ApoA5 plasmid was injected by tail vein prior to LPS/d-GalN treatment. The expressions of ApoA5, toll-like receptor 4 (TLR4), myeloid differentiation factor 88 (MyD88), and nuclear factor kappa B p65 (NF-κBp65) were assessed by real-time PCR and western blotting. Serum alanine aminotransferase (ALT) and tumor necrosis factor-α (TNF-α) levels were measured using automatic biochemical analyzer. Histological assessment and immunohistochemical (IHC) staining were conducted. Survival rate after LPS/d-GalN administration was also determined with Kaplan–Meier curve. Meanwhile, the expression of ApoA5 in injured huh7 cells was tested. Cell apoptosis analysis was performed after huh7 cells were transfected with ApoA5 plasmid and stimulated with LPS. The expressions of ApoA5 decreased both in injured huh7 cells and FHF mice. ApoA5 overexpression reduced cell death rate using flow cytometry. ApoA5 not only decreased the serum ALT and TNF-α levels but also attenuated hepatic damage in hematoxylin–eosin (HE)-stained liver section. The protein expressions of TLR4, MyD88 and NF-κBp65 were inhibited when ApoA5 overexpressed. But the inhibitory effect would weaken with the increasing concentration of LPS in spite of ApoA5 overexpression. Besides, ApoA5 improved liver injury in a dose-dependent manner and the survival rate in FHF mice increased with increasing concentration of ApoA5. ApoA5 had a protective effect against LPS/d-GalN-induced fulminant liver failure in mice within a certain range by inhibiting TLR4-mediated NF-κB pathway." @default.
• W2946974785 created "2019-06-07" @default.
• W2946974785 creator A5006234538 @default.
• W2946974785 creator A5014268039 @default.
• W2946974785 creator A5033469589 @default.
• W2946974785 creator A5043296871 @default.
• W2946974785 creator A5045780325 @default.
• W2946974785 creator A5061992559 @default.
• W2946974785 date "2019-05-10" @default.
• W2946974785 modified "2023-10-18" @default.
• W2946974785 title "Apolipoprotein A5 alleviates LPS/d-GalN-induced fulminant liver failure in mice by inhibiting TLR4-mediated NF-κB pathway" @default.
• W2946974785 cites W1544998723 @default.
• W2946974785 cites W1842508081 @default.
• W2946974785 cites W1968650639 @default.
• W2946974785 cites W2002779860 @default.
• W2946974785 cites W2004709850 @default.
• W2946974785 cites W2014973641 @default.
• W2946974785 cites W2023466812 @default.
• W2946974785 cites W2023846838 @default.
• W2946974785 cites W2039204216 @default.
• W2946974785 cites W2052793652 @default.
• W2946974785 cites W2059366554 @default.
• W2946974785 cites W2072342588 @default.
• W2946974785 cites W2078235152 @default.
• W2946974785 cites W2094762349 @default.
• W2946974785 cites W2122708604 @default.
• W2946974785 cites W2124956149 @default.
• W2946974785 cites W2129413932 @default.
• W2946974785 cites W2133025759 @default.
• W2946974785 cites W2158721108 @default.
• W2946974785 cites W2190888443 @default.
• W2946974785 cites W2575447090 @default.
• W2946974785 cites W2592727801 @default.
• W2946974785 cites W2598460202 @default.
• W2946974785 cites W2613642286 @default.
• W2946974785 cites W2614484469 @default.
• W2946974785 cites W2745854656 @default.
• W2946974785 cites W2883350567 @default.
• W2946974785 cites W4249621027 @default.
• W2946974785 doi "https://doi.org/10.1186/s12967-019-1900-9" @default.
• W2946974785 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6511152" @default.
• W2946974785 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/31077206" @default.
• W2946974785 hasPublicationYear "2019" @default.
• W2946974785 type Work @default.
• W2946974785 sameAs 2946974785 @default.
• W2946974785 citedByCount "14" @default.
• W2946974785 countsByYear W29469747852020 @default.
• W2946974785 countsByYear W29469747852021 @default.
• W2946974785 countsByYear W29469747852022 @default.
• W2946974785 countsByYear W29469747852023 @default.
• W2946974785 crossrefType "journal-article" @default.
• W2946974785 hasAuthorship W2946974785A5006234538 @default.
• W2946974785 hasAuthorship W2946974785A5014268039 @default.
• W2946974785 hasAuthorship W2946974785A5033469589 @default.
• W2946974785 hasAuthorship W2946974785A5043296871 @default.
• W2946974785 hasAuthorship W2946974785A5045780325 @default.
• W2946974785 hasAuthorship W2946974785A5061992559 @default.
• W2946974785 hasBestOaLocation W29469747851 @default.
• W2946974785 hasConcept C125473707 @default.
• W2946974785 hasConcept C126322002 @default.
• W2946974785 hasConcept C134018914 @default.
• W2946974785 hasConcept C142724271 @default.
• W2946974785 hasConcept C171056886 @default.
• W2946974785 hasConcept C17991360 @default.
• W2946974785 hasConcept C204232928 @default.
• W2946974785 hasConcept C2776070231 @default.
• W2946974785 hasConcept C2776637226 @default.
• W2946974785 hasConcept C2776795407 @default.
• W2946974785 hasConcept C2776914184 @default.
• W2946974785 hasConcept C2779609443 @default.
• W2946974785 hasConcept C2911091166 @default.
• W2946974785 hasConcept C2911118192 @default.
• W2946974785 hasConcept C71924100 @default.
• W2946974785 hasConcept C86803240 @default.
• W2946974785 hasConcept C95444343 @default.
• W2946974785 hasConceptScore W2946974785C125473707 @default.
• W2946974785 hasConceptScore W2946974785C126322002 @default.
• W2946974785 hasConceptScore W2946974785C134018914 @default.
• W2946974785 hasConceptScore W2946974785C142724271 @default.
• W2946974785 hasConceptScore W2946974785C171056886 @default.
• W2946974785 hasConceptScore W2946974785C17991360 @default.
• W2946974785 hasConceptScore W2946974785C204232928 @default.
• W2946974785 hasConceptScore W2946974785C2776070231 @default.
• W2946974785 hasConceptScore W2946974785C2776637226 @default.
• W2946974785 hasConceptScore W2946974785C2776795407 @default.
• W2946974785 hasConceptScore W2946974785C2776914184 @default.
• W2946974785 hasConceptScore W2946974785C2779609443 @default.
• W2946974785 hasConceptScore W2946974785C2911091166 @default.
• W2946974785 hasConceptScore W2946974785C2911118192 @default.
• W2946974785 hasConceptScore W2946974785C71924100 @default.
• W2946974785 hasConceptScore W2946974785C86803240 @default.
• W2946974785 hasConceptScore W2946974785C95444343 @default.
• W2946974785 hasFunder F4320321001 @default.
• W2946974785 hasIssue "1" @default.
• W2946974785 hasLocation W29469747851 @default.
• W2946974785 hasLocation W29469747852 @default.
• W2946974785 hasLocation W29469747853 @default.
• W2946974785 hasLocation W29469747854 @default.
• W2946974785 hasOpenAccess W2946974785 @default.
• W2946974785 hasPrimaryLocation W29469747851 @default.

• next